Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-10-18

Clinical Trial Update: The Effects of Glucomannan on Weight Loss [Phase 1]

View source ↗

Summary

This clinical trial update reports completion of a Phase 1 study evaluating the effects of glucomannan on weight loss in individuals with obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glucomannan (glucomannan)

Snippet

Sponsor: Northeast College of Health Sciences | Conditions: Obesity | Phase 1 | Status: COMPLETED